This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 Sep;138(9):1238-40.

doi: 10.1001/archderm.138.9.1238.

Alefacept for psoriasis: promising drug, open questions

Affiliations

PMID: 12224990
DOI: 10.1001/archderm.138.9.1238

Comment

Alefacept for psoriasis: promising drug, open questions

Luigi Naldi. Arch Dermatol. 2002 Sep.

. 2002 Sep;138(9):1238-40.

doi: 10.1001/archderm.138.9.1238.

Author

Affiliation

¹ Clinica Dermatologica, Ospedali Riuniti, Largo Barozzi, 24100 Bergamo, Italy.

PMID: 12224990
DOI: 10.1001/archderm.138.9.1238

No abstract available

PubMed Disclaimer

Comment on

Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.
Ellis CN, Krueger GG; Alefacept Clinical Study Group. Ellis CN, et al. N Engl J Med. 2001 Jul 26;345(4):248-55. doi: 10.1056/NEJM200107263450403. N Engl J Med. 2001. PMID: 11474662 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems